The current work was partially supported by the National Basic Research Program of China(973 Program,no.2011CB505105);We thank Guoyan Yang from National Institute of Complementary Medicine,University of Western Medicine for her suggestions in data synthesis.
Objective:To systematically evaluate the effectiveness and safety of Chinese herbal medicine (CHM) plus nucleotide analogues (NAs) for treating compensated HBV-related cirrhosis,the early stage of cirrhosis.Methods:Pu...
Supported by the Major State Basic Research Development Program of China(973 Program),No.2001CB510001
AIM: To find new serum biomarkers for liver cirrhosis (LC) in chronic carriers of hepatitis B virus (HBV).METHODS: Surface enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry was used to ...